{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:39:49Z","timestamp":1792798789656,"version":"4.5.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12967-5","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T10:10:28Z","timestamp":1792750228000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dissecting polycystic metabolic ovarian syndrome heterogeneity (PMOS): multi-omics, AI subtyping, and precision management"],"prefix":"10.1007","volume":"53","author":[{"given":"Sristy","family":"Pradhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0780-0492","authenticated-orcid":false,"given":"Abilash Valsala","family":"Gopalakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,23]]},"reference":[{"key":"12967_CR1","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00404-024-07607-x","volume":"3103 310","author":"N Salari","year":"2024","unstructured":"Salari N, Nankali A, Ghanbari A et al (2024) Global prevalence of polycystic ovary syndrome in women worldwide: a comprehensive systematic review and meta-analysis. Arch Gynecol Obstet 2024 3103 310:1303\u20131314. https:\/\/doi.org\/10.1007\/s00404-024-07607-x","journal-title":"Arch Gynecol Obstet 2024"},{"key":"12967_CR2","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.2147\/IJWH.S556627","volume":"17","author":"R Xu","year":"2025","unstructured":"Xu R, Li X, Sang L et al (2025) Global Burden and Future Trends of Polycystic Ovary Syndrome: Insights from the GBD 2021 Study. Int J Womens Health 17:3707\u20133720. https:\/\/doi.org\/10.2147\/IJWH.S556627","journal-title":"Int J Womens Health"},{"key":"12967_CR3","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.fertnstert.2025.09.025","volume":"124","author":"A Dokras","year":"2025","unstructured":"Dokras A (2025) Polycystic ovary syndrome in 2025\u2014insights and innovations. Fertil Steril 124:907\u2013909. https:\/\/doi.org\/10.1016\/j.fertnstert.2025.09.025","journal-title":"Fertil Steril"},{"key":"12967_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmaf030","author":"ACH Neven","year":"2026","unstructured":"Neven ACH, Forslund M, Ranasinha S et al (2026) Prevalence of polycystic ovary syndrome: a global and regional systematic review and meta-analysis. Hum Reprod Update. https:\/\/doi.org\/10.1093\/humupd\/dmaf030","journal-title":"Hum Reprod Update"},{"key":"12967_CR5","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","volume":"189","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, Tay CT, Laven JJE et al (2023) Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur J Endocrinol 189:G43\u2013G64. https:\/\/doi.org\/10.1093\/ejendo\/lvad096","journal-title":"Eur J Endocrinol"},{"key":"12967_CR6","doi-asserted-by":"publisher","first-page":"e2440583","DOI":"10.1001\/JAMANETWORKOPEN.2024.40583","volume":"7","author":"MA Ganie","year":"2024","unstructured":"Ganie MA, Chowdhury S, Malhotra N et al (2024) Prevalence, Phenotypes, and Comorbidities of Polycystic Ovary Syndrome Among Indian Women. JAMA Netw Open 7:e2440583\u2013e2440583. https:\/\/doi.org\/10.1001\/JAMANETWORKOPEN.2024.40583","journal-title":"JAMA Netw Open"},{"issue":"101","key":"12967_CR7","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/s41572-024-00511-3","volume":"2024","author":"E Stener-Victorin","year":"2024","unstructured":"Stener-Victorin E, Teede H, Norman RJ et al (2024) Polycystic ovary syndrome. Nat Rev Dis Prim 2024(101):1027\u2013. https:\/\/doi.org\/10.1038\/s41572-024-00511-3","journal-title":"Nat Rev Dis Prim"},{"key":"12967_CR8","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/s12916-025-04221-9","volume":"231 23","author":"AD Bizuneh","year":"2025","unstructured":"Bizuneh AD, Kiconco S, Earnest A et al (2025) The PCOS Phenotypes in Unselected Populations (P-PUP) study: participant clinical features and data harmonization on analysis of individual participant data. BMC Med 2025 231 23:420\u2013. https:\/\/doi.org\/10.1186\/s12916-025-04221-9","journal-title":"BMC Med 2025"},{"key":"12967_CR9","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1038\/s41591-025-03984-1","volume":"31","author":"X Gao","year":"2025","unstructured":"Gao X, Zhao S, Du Y et al (2025) Data-driven subtypes of polycystic ovary syndrome and their association with clinical outcomes. Nat Med 31:4214\u20134224. https:\/\/doi.org\/10.1038\/s41591-025-03984-1","journal-title":"Nat Med"},{"key":"12967_CR10","doi-asserted-by":"publisher","unstructured":"Xu D, Jia D, Fang X et al (2025) Integrative multi-omics analysis of druggable genes for therapeutic target identification in polycystic ovary syndrome. J Ovarian Res 181 18:293-. https:\/\/doi.org\/10.1186\/s13048-025-01889-8","DOI":"10.1186\/s13048-025-01889-8"},{"key":"12967_CR11","doi-asserted-by":"publisher","unstructured":"Ghaderzadeh M, Garavand A, Salehnasab C (2025) Artificial intelligence in polycystic ovary syndrome: a systematic review of diagnostic and predictive applications. BMC Med Informatics Decis Mak 251 25:427-. https:\/\/doi.org\/10.1186\/s12911-025-03255-6","DOI":"10.1186\/s12911-025-03255-6"},{"key":"12967_CR12","doi-asserted-by":"publisher","first-page":"1426517","DOI":"10.3389\/fendo.2024.1426517","volume":"15","author":"Y Chen","year":"2024","unstructured":"Chen Y, Xie M, Wu S et al (2024) Multi-omics approach to reveal follicular metabolic changes and their effects on oocyte competence in PCOS patients. Front Endocrinol (Lausanne) 15:1426517. https:\/\/doi.org\/10.3389\/fendo.2024.1426517","journal-title":"Front Endocrinol (Lausanne)"},{"key":"12967_CR13","doi-asserted-by":"publisher","first-page":"1572427","DOI":"10.3389\/fendo.2025.1572427","volume":"16","author":"KA Burns","year":"2025","unstructured":"Burns KA, Stuckey AW, Wilson SG et al (2025) Characterization of distinct polycystic ovary syndrome subtypes by cluster and principal component analyses. Front Endocrinol (Lausanne) 16:1572427. https:\/\/doi.org\/10.3389\/fendo.2025.1572427","journal-title":"Front Endocrinol (Lausanne)"},{"key":"12967_CR14","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1210\/clinem\/dgae298","volume":"109","author":"K van der Ham","year":"2024","unstructured":"van der Ham K, Moolhuijsen LME, Brewer K et al (2024) Clustering Identifies Subtypes With Different Phenotypic Characteristics in Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab 109:3096\u20133107. https:\/\/doi.org\/10.1210\/clinem\/dgae298","journal-title":"J Clin Endocrinol Metab"},{"key":"12967_CR15","doi-asserted-by":"publisher","first-page":"7611","DOI":"10.1038\/s41467-025-62951-z","volume":"161 16","author":"Y Wang","year":"2025","unstructured":"Wang Y, Wu J, Zhang G et al (2025) Androgens drive SLC1A5-dependent metabolic reprogramming in polycystic ovary syndrome. Nat Commun 2025 161 16:7611. https:\/\/doi.org\/10.1038\/s41467-025-62951-z","journal-title":"Nat Commun 2025"},{"key":"12967_CR16","doi-asserted-by":"publisher","unstructured":"Babu A, Ramanathan G (2023) Multi-omics insights and therapeutic implications in polycystic ovary syndrome: a review. Funct Integr Genomics 232 23:130-. https:\/\/doi.org\/10.1007\/s10142-023-01053-9","DOI":"10.1007\/s10142-023-01053-9"},{"key":"12967_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2147\/IJWH.S344542","volume":"14","author":"C Xing","year":"2022","unstructured":"Xing C, Zhang J, Zhao H, He B (2022) Effect of Sex Hormone-Binding Globulin on Polycystic Ovary Syndrome: Mechanisms, Manifestations, Genetics, and Treatment. Int J Womens Health 14:91\u2013105. https:\/\/doi.org\/10.2147\/IJWH.S344542","journal-title":"Int J Womens Health"},{"key":"12967_CR18","doi-asserted-by":"publisher","unstructured":"Zhang Z, Hong Y, Chen M et al (2020) Serum metabolomics reveals metabolic profiling for women with hyperandrogenism and insulin resistance in polycystic ovary syndrome. Metabolomics 16. https:\/\/doi.org\/10.1007\/s11306-020-1642-y","DOI":"10.1007\/s11306-020-1642-y"},{"key":"12967_CR19","doi-asserted-by":"publisher","first-page":"e4275","DOI":"10.1210\/clinem\/dgab422","volume":"106","author":"A Abbara","year":"2021","unstructured":"Abbara A, Dhillo WS (2021) Targeting Elevated GnRH Pulsatility to Treat Polycystic Ovary Syndrome. J Clin Endocrinol Metab 106:e4275\u2013e4277. https:\/\/doi.org\/10.1210\/clinem\/dgab422","journal-title":"J Clin Endocrinol Metab"},{"key":"12967_CR20","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.freeradbiomed.2024.10.312","volume":"225","author":"K Liu","year":"2024","unstructured":"Liu K, Wei H, Nong W et al (2024) Nampt\/SIRT2\/LDHA pathway-mediated lactate production regulates follicular dysplasia in polycystic ovary syndrome. Free Radic Biol Med 225:776\u2013793. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.10.312","journal-title":"Free Radic Biol Med"},{"key":"12967_CR21","doi-asserted-by":"publisher","first-page":"1169232","DOI":"10.3389\/fimmu.2023.1169232","volume":"14","author":"J Wang","year":"2023","unstructured":"Wang J, Yin T, Liu S (2023) Dysregulation of immune response in PCOS organ system. Front Immunol 14:1169232. https:\/\/doi.org\/10.3389\/fimmu.2023.1169232","journal-title":"Front Immunol"},{"key":"12967_CR22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/10408363.2024.2430775","volume":"62","author":"A Naigaonkar","year":"2025","unstructured":"Naigaonkar A, Dadachanji R, Kumari M, Mukherjee S (2025) Insight into metabolic dysregulation of polycystic ovary syndrome utilizing metabolomic signatures: a narrative review. Crit Rev Clin Lab Sci 62:85\u2013112. https:\/\/doi.org\/10.1080\/10408363.2024.2430775","journal-title":"Crit Rev Clin Lab Sci"},{"key":"12967_CR23","doi-asserted-by":"publisher","unstructured":"Kempegowda P, Melson E, Manolopoulos KN et al (2020) Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome. Ther Adv Endocrinol Metab 11. https:\/\/doi.org\/10.1177\/2042018820934319","DOI":"10.1177\/2042018820934319"},{"key":"12967_CR24","doi-asserted-by":"publisher","unstructured":"Xu J, Chen WH, Huang MN et al (2025) Recent advances in reprogramming lactate metabolism in polycystic ovary syndrome. J Ovarian Res 181 18:221-. https:\/\/doi.org\/10.1186\/s13048-025-01797-x","DOI":"10.1186\/s13048-025-01797-x"},{"key":"12967_CR25","doi-asserted-by":"publisher","first-page":"1523488","DOI":"10.3389\/fendo.2025.1523488","volume":"16","author":"X Zhao","year":"2025","unstructured":"Zhao X, Meng Q, Liu S et al (2025) Integrated multi-omics analysis reveals complement component 3 as a central driver of immune dysregulation in polycystic ovary syndrome. Front Endocrinol (Lausanne) 16:1523488. https:\/\/doi.org\/10.3389\/fendo.2025.1523488","journal-title":"Front Endocrinol (Lausanne)"},{"key":"12967_CR26","doi-asserted-by":"publisher","unstructured":"Luo M, Yang X, Li L et al (2025) Integrated transcriptomic and co-expression network analysis identifies immune-metabolic biomarkers of polycystic ovary syndrome in granulosa cells. J Ovarian Res 181 18:248-. https:\/\/doi.org\/10.1186\/s13048-025-01835-8","DOI":"10.1186\/s13048-025-01835-8"},{"issue":"151","key":"12967_CR27","doi-asserted-by":"publisher","first-page":"152970","DOI":"10.1038\/s41598-024-81110-w","volume":"2024","author":"X Zhu","year":"2025","unstructured":"Zhu X, Han Y, Feng Y et al (2025) Identification of molecular characteristics in polycystic ovary syndrome using single-cell and transcriptome analysis. Sci Rep 2024(151):152970\u2013. https:\/\/doi.org\/10.1038\/s41598-024-81110-w","journal-title":"Sci Rep"},{"key":"12967_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12958-024-01195-w","volume":"221 22","author":"S Li","year":"2024","unstructured":"Li S, Li Y, Sun Y et al (2024) Deconvolution at the single-cell level reveals ovarian cell-type-specific transcriptomic changes in PCOS. Reprod Biol Endocrinol 2024 221 22:24. https:\/\/doi.org\/10.1186\/s12958-024-01195-w","journal-title":"Reprod Biol Endocrinol 2024"},{"key":"12967_CR29","doi-asserted-by":"publisher","first-page":"1787902","DOI":"10.3389\/fendo.2026.1787902","volume":"17","author":"P Pinton","year":"2026","unstructured":"Pinton P (2026) A perspective on precision therapeutics in polycystic ovary syndrome: integrating multi-omics, AI-driven stratification, and emerging biologics. Front Endocrinol (Lausanne) 17:1787902. https:\/\/doi.org\/10.3389\/fendo.2026.1787902","journal-title":"Front Endocrinol (Lausanne)"},{"key":"12967_CR30","doi-asserted-by":"publisher","first-page":"e1003132","DOI":"10.1371\/journal.pmed.1003132","volume":"17","author":"M Dapas","year":"2020","unstructured":"Dapas M, Lin FTJ, Nadkarni GN et al (2020) Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis. PLOS Med 17:e1003132. https:\/\/doi.org\/10.1371\/journal.pmed.1003132","journal-title":"PLOS Med"},{"key":"12967_CR31","doi-asserted-by":"publisher","first-page":"713592","DOI":"10.3389\/fendo.2021.713592","volume":"12","author":"Z Lin","year":"2021","unstructured":"Lin Z, Feng W, Liu Y et al (2021) Machine Learning to Identify Metabolic Subtypes of Obesity: A Multi-Center Study. Front Endocrinol (Lausanne) 12:713592. https:\/\/doi.org\/10.3389\/fendo.2021.713592","journal-title":"Front Endocrinol (Lausanne)"},{"key":"12967_CR32","doi-asserted-by":"publisher","unstructured":"Liu L, Gao Q, Huang J et al (2026) Comprehensive analysis of proteomics and lactylation proteomics in ovarian granulosa cells of patients with polycystic ovary syndrome. Clin Proteomics 231 23:9-. https:\/\/doi.org\/10.1186\/s12014-025-09575-z","DOI":"10.1186\/s12014-025-09575-z"},{"key":"12967_CR33","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s41392-025-02468-5","volume":"101 10","author":"C Yu","year":"2025","unstructured":"Yu C, Liu T, Wang Y et al (2025) Pyruvate kinase M2-mediated histone lactylation alters three-dimensional genomic architecture in polycystic ovary syndrome. Signal Transduct Target Ther 2025 101 10:376\u2013. https:\/\/doi.org\/10.1038\/s41392-025-02468-5","journal-title":"Signal Transduct Target Ther 2025"},{"key":"12967_CR34","doi-asserted-by":"publisher","unstructured":"Lili L, Kunces LJ, Meydan C et al (2025) A multi-omic study profiles women with PCOS to reveal unique gut microbiome compositions. Precis Clin Med 8. https:\/\/doi.org\/10.1093\/pcmedi\/pbaf012","DOI":"10.1093\/pcmedi\/pbaf012"},{"key":"12967_CR35","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1210\/endrev\/bnac001","volume":"43","author":"M Dapas","year":"2022","unstructured":"Dapas M, Dunaif A (2022) Deconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification. Endocr Rev 43:927\u2013965. https:\/\/doi.org\/10.1210\/endrev\/bnac001","journal-title":"Endocr Rev"},{"key":"12967_CR36","doi-asserted-by":"publisher","first-page":"1113840","DOI":"10.3389\/fmed.2023.1113840","volume":"10","author":"W Fu","year":"2023","unstructured":"Fu W, Kuang Y (2023) Role of luteinizing hormone elevation in outcomes of ovulation induction with letrozole for polycystic ovary syndrome. Front Med 10:1113840. https:\/\/doi.org\/10.3389\/fmed.2023.1113840","journal-title":"Front Med"},{"key":"12967_CR37","doi-asserted-by":"publisher","first-page":"16247","DOI":"10.3390\/ijms242216247","volume":"24","author":"CH Zhang","year":"2023","unstructured":"Zhang CH, Liu XY, Wang J (2023) Essential Role of Granulosa Cell Glucose and Lipid Metabolism on Oocytes and the Potential Metabolic Imbalance in Polycystic Ovary Syndrome. Int J Mol Sci 2023 24:16247. https:\/\/doi.org\/10.3390\/ijms242216247","journal-title":"Int J Mol Sci 2023"},{"key":"12967_CR38","doi-asserted-by":"publisher","unstructured":"Kobayashi H, Imanaka S (2024) Recent progress in metabolomics for analyzing common infertility conditions that affect ovarian function. Reprod Med Biol 23. https:\/\/doi.org\/10.1002\/rmb2.12609","DOI":"10.1002\/rmb2.12609"},{"key":"12967_CR39","doi-asserted-by":"crossref","unstructured":"Naqvi I, Bandyopadhyay A, Panda A, Hareramadas B (2025) Polycystic Ovarian Syndrome: A Review of Multi-omics Analyses. Reprod Sci 323 32:618\u2013646","DOI":"10.1007\/s43032-025-01789-8"},{"key":"12967_CR40","doi-asserted-by":"publisher","first-page":"956406","DOI":"10.3389\/fmolb.2022.956406","volume":"9","author":"W Wang","year":"2022","unstructured":"Wang W, Jiang Q, Niu Y et al (2022) Proteomics and bioinformatics analysis of follicular fluid from patients with polycystic ovary syndrome. Front Mol Biosci 9:956406. https:\/\/doi.org\/10.3389\/fmolb.2022.956406","journal-title":"Front Mol Biosci"},{"key":"12967_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.biochi.2025.09.015","volume":"240","author":"R Dadachanji","year":"2026","unstructured":"Dadachanji R, Bhingardeve S, Desai SK et al (2026) Altered hemostatic dynamics and its regulation in follicular microenvironment of women with polycystic ovary syndrome. Biochimie 240:31\u201341. https:\/\/doi.org\/10.1016\/j.biochi.2025.09.015","journal-title":"Biochimie"},{"key":"12967_CR42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12958-025-01396-x","volume":"231 23","author":"W Shi","year":"2025","unstructured":"Shi W, Lin H, Di W et al (2025) Granulosa cell RNA-Seq insights into senescence and sphingolipid metabolism disorder in PCOS: aspirin as a potential therapeutic drug. Reprod Biol Endocrinol 2025 231 23:61. https:\/\/doi.org\/10.1186\/s12958-025-01396-x","journal-title":"Reprod Biol Endocrinol 2025"},{"key":"12967_CR43","doi-asserted-by":"publisher","unstructured":"Yang X, Liu P, He H et al (2024) Comprehensive analysis of ovarian granulosa cell proteomics and phosphoproteomics in PCOS patients without insulin resistance. Mol Hum Reprod 30. https:\/\/doi.org\/10.1093\/molehr\/gaae005","DOI":"10.1093\/molehr\/gaae005"},{"key":"12967_CR44","doi-asserted-by":"publisher","unstructured":"Xu K, Zhang S, Guo L et al (2026) Interpreting the molecular and cellular landscape of PCOS through bulk transcriptomics, single-cell transcriptomics and machine learning. J Ovarian Res 191 19:46-. https:\/\/doi.org\/10.1186\/s13048-025-01956-0","DOI":"10.1186\/s13048-025-01956-0"},{"key":"12967_CR45","doi-asserted-by":"publisher","unstructured":"He R, Zhao Z, Yang Y, Liang X (2020) Using bioinformatics and metabolomics to identify altered granulosa cells in patients with diminished ovarian reserve. PeerJ 8. https:\/\/doi.org\/10.7717\/peerj.9812","DOI":"10.7717\/peerj.9812"},{"key":"12967_CR46","doi-asserted-by":"publisher","unstructured":"Luo M, Yang X, Zhou M et al (2024) Integrated single-cell and spatial transcriptomics reveal microenvironment disruptions by androgen in mouse ovary. https:\/\/doi.org\/10.1016\/j.isci.2024.111028. iScience 27:","DOI":"10.1016\/j.isci.2024.111028"},{"key":"12967_CR47","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s11658-026-00879-y","volume":"31","author":"X Zhao","year":"2026","unstructured":"Zhao X, Zhao Y, Jiang Y et al (2026) HK2-driven histone H3K18 lactylation promotes stromal cell senescence and decidualization deficiency in URSA via CUX1-mediated SASP factor transcription. Cell Mol Biol Lett 31:31. https:\/\/doi.org\/10.1186\/s11658-026-00879-y","journal-title":"Cell Mol Biol Lett"},{"key":"12967_CR48","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jare.2024.11.010","volume":"75","author":"X Hu","year":"2025","unstructured":"Hu X, ting, Wu X, feng, Xu Jyi, Xu X (2025) Lactate-mediated lactylation in human health and diseases: Progress and remaining challenges. J Adv Res 75:229\u2013248. https:\/\/doi.org\/10.1016\/j.jare.2024.11.010","journal-title":"J Adv Res"},{"key":"12967_CR49","doi-asserted-by":"publisher","first-page":"104420","DOI":"10.1016\/j.drudis.2025.104420","volume":"30","author":"X Yan","year":"2025","unstructured":"Yan X, Zhang G, Wei H et al (2025) Lysine lactylation: Regulatory mechanisms, role in health and disease, and its therapeutic potential. Drug Discov Today 30:104420. https:\/\/doi.org\/10.1016\/j.drudis.2025.104420","journal-title":"Drug Discov Today"},{"key":"12967_CR50","doi-asserted-by":"publisher","unstructured":"Wu G, Chen M, He T et al (2025) Lactylation of CREB is required for FSH-induced proliferation and differentiation of ovarian granulosa cells. Nucleic Acids Res 53. https:\/\/doi.org\/10.1093\/nar\/gkaf882","DOI":"10.1093\/nar\/gkaf882"},{"key":"12967_CR51","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1038\/s41467-026-68441-0","volume":"171 17","author":"H Shan","year":"2026","unstructured":"Shan H, Wang Y, Liao B et al (2026) Women with polycystic ovary syndrome exhibit impaired endometrial receptivity with excessive ER\u03b1 and histone lactylation. Nat Commun 2026 171 17:1739. https:\/\/doi.org\/10.1038\/s41467-026-68441-0","journal-title":"Nat Commun 2026"},{"key":"12967_CR52","doi-asserted-by":"publisher","first-page":"1610713","DOI":"10.3389\/fimmu.2025.1610713","volume":"16","author":"H Ma","year":"2025","unstructured":"Ma H, Qi D, Xu Y et al (2025) PLK2 as a key regulator of glycolysis and immune dysregulation in polycystic ovary syndrome. Front Immunol 16:1610713. https:\/\/doi.org\/10.3389\/fimmu.2025.1610713","journal-title":"Front Immunol"},{"key":"12967_CR53","doi-asserted-by":"publisher","first-page":"5255","DOI":"10.2147\/DDDT.S525651","volume":"19","author":"Z Cao","year":"2025","unstructured":"Cao Z, Zhou Q, An J et al (2025) Glycolytic Dysfunction in Granulosa Cells and Its Contribution to Metabolic Dysfunction in Polycystic Ovary Syndrome. Drug Des Devel Ther 19:5255\u20135270. https:\/\/doi.org\/10.2147\/DDDT.S525651","journal-title":"Drug Des Devel Ther"},{"key":"12967_CR54","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/antiox14101235","volume":"14","author":"B Zhao","year":"2025","unstructured":"Zhao B, Fan L, Liu M et al (2025) Androgen-Induced Lactic Acid Accumulation Contributes to the Apoptosis of Ovarian Granulosa Cells in Polycystic Ovary Syndrome Mice. Antioxid 2025 14:14. https:\/\/doi.org\/10.3390\/antiox14101235","journal-title":"Antioxid 2025"},{"key":"12967_CR55","doi-asserted-by":"publisher","unstructured":"Su P, Chen C, Sun Y (2025) Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation. J Ovarian Res 181 18:34-. https:\/\/doi.org\/10.1186\/s13048-025-01621-6","DOI":"10.1186\/s13048-025-01621-6"},{"key":"12967_CR56","doi-asserted-by":"publisher","unstructured":"Qian Y, Tong Y, Zeng Y et al (2024) Integrated lipid metabolomics and proteomics analysis reveal the pathogenesis of polycystic ovary syndrome. J Transl Med 221 22:364-. https:\/\/doi.org\/10.1186\/s12967-024-05167-x","DOI":"10.1186\/s12967-024-05167-x"},{"key":"12967_CR57","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.csbj.2025.04.011","volume":"27","author":"M Li","year":"2025","unstructured":"Li M, He Z, Shi L et al (2025) Intelligent detection for Polycystic Ovary Syndrome (PCOS): Taxonomy, datasets and detection tools. Comput Struct Biotechnol J 27:1578\u20131599. https:\/\/doi.org\/10.1016\/j.csbj.2025.04.011","journal-title":"Comput Struct Biotechnol J"},{"key":"12967_CR58","doi-asserted-by":"publisher","first-page":"1709581","DOI":"10.3389\/fnut.2025.1709581","volume":"12","author":"H Xu","year":"2026","unstructured":"Xu H, Liu X, Sun W et al (2026) Multi-omics elucidation of Lactiplantibacillus plantarum NKK20 in preventing PCOS via the gut-ovary axis: SCFAs-mediated microbiota-metabolite-immune crosstalk. Front Nutr 12:1709581. https:\/\/doi.org\/10.3389\/fnut.2025.1709581","journal-title":"Front Nutr"},{"key":"12967_CR59","doi-asserted-by":"publisher","first-page":"1719631","DOI":"10.3389\/fendo.2025.1719631","volume":"16","author":"B Yao","year":"2025","unstructured":"Yao B, Yu X, Zhang Y et al (2025) Development and validation of an explainable machine learning and nomogram model for early detection and risk stratification of polycystic ovary syndrome: a multicenter study. Front Endocrinol (Lausanne) 16:1719631. https:\/\/doi.org\/10.3389\/fendo.2025.1719631","journal-title":"Front Endocrinol (Lausanne)"},{"key":"12967_CR60","doi-asserted-by":"publisher","unstructured":"Agirsoy M, Oehlschlaeger MA (2025) A machine learning approach for non-invasive PCOS diagnosis from ultrasound and clinical features. Sci Reports 151 15:33638-. https:\/\/doi.org\/10.1038\/s41598-025-10453-9","DOI":"10.1038\/s41598-025-10453-9"},{"key":"12967_CR61","first-page":"49","volume":"1","author":"S-A Sadegh-Zadeh","year":"2026","unstructured":"Sadegh-Zadeh S-A, Behforouz A, Chaparnia M et al (2026) Advancing PCOS Diagnosis: Harnessing the Power of AI and Machine Learning for Enhanced Accuracy and Efficiency. Front Biomed Signal Process 1:49\u201370. https:\/\/doi.org\/gao","journal-title":"Front Biomed Signal Process"},{"issue":"181","key":"12967_CR62","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13048-024-01583-1","volume":"2024","author":"W Chen","year":"2025","unstructured":"Chen W, Miao J, Chen J, Chen J (2025) Development of machine learning models for diagnostic biomarker identification and immune cell infiltration analysis in PCOS. J Ovarian Res 2024(181):181\u2013. https:\/\/doi.org\/10.1186\/s13048-024-01583-1","journal-title":"J Ovarian Res"},{"key":"12967_CR63","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.3390\/biomedicines12071496","volume":"12","author":"AE Mohr","year":"2024","unstructured":"Mohr AE, Ortega-Santos CP, Whisner CM et al (2024) Navigating Challenges and Opportunities in Multi-Omics Integration for Personalized Healthcare. Biomedicines 12:1496. https:\/\/doi.org\/10.3390\/biomedicines12071496","journal-title":"Biomedicines"},{"key":"12967_CR64","doi-asserted-by":"publisher","unstructured":"\u00d6zer \u00d6F, \u0130brahimo\u011flu AZ, G\u00fcl AZ et al (2025) Mass spectrometry-based untargeted metabolomics study of polycystic ovary syndrome. J Ovarian Res 181 18:255-. https:\/\/doi.org\/10.1186\/s13048-025-01842-9","DOI":"10.1186\/s13048-025-01842-9"},{"key":"12967_CR65","doi-asserted-by":"publisher","first-page":"e0313494","DOI":"10.1371\/journal.pone.0313494","volume":"20","author":"JY Chen","year":"2025","unstructured":"Chen JY, Chen WJ, Zhu ZY et al (2025) Screening of serum biomarkers in patients with PCOS through lipid omics and ensemble machine learning. PLoS ONE 20:e0313494. https:\/\/doi.org\/10.1371\/journal.pone.0313494","journal-title":"PLoS ONE"},{"key":"12967_CR66","doi-asserted-by":"publisher","unstructured":"Xu H, Mao L, Huang W et al (2025) Gene association study between polycystic ovary syndrome and metabolic syndrome: a transcriptomic analysis and machine learning approach. J Ovarian Res 181 18:220-. https:\/\/doi.org\/10.1186\/s13048-025-01787-z","DOI":"10.1186\/s13048-025-01787-z"},{"key":"12967_CR67","doi-asserted-by":"publisher","unstructured":"Zhang C, Lin Z, Lin Y, Ma H (2025) Single-cell transcriptomics uncovering a critical AKT-LONP1-STAR axis in ovarian hyperandrogenism of PCOS. J Ovarian Res 181 18:275-. https:\/\/doi.org\/10.1186\/s13048-025-01837-6","DOI":"10.1186\/s13048-025-01837-6"},{"key":"12967_CR68","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2174\/0109298673368951250404170052","volume":"33","author":"PL Narayanan","year":"2025","unstructured":"Narayanan PL, Sugumar S, Rushendran R, Vellapandian C (2025) Next-generation Approaches in Targeting Polycystic Ovarian Syndrome: Innovative Strategies. Curr Med Chem 33:57\u201375. https:\/\/doi.org\/10.2174\/0109298673368951250404170052","journal-title":"Curr Med Chem"},{"key":"12967_CR69","doi-asserted-by":"publisher","first-page":"120425","DOI":"10.1016\/j.cca.2025.120425","volume":"576","author":"I Singh","year":"2025","unstructured":"Singh I, Moar K, Maurya PK (2025) Diagnostic and prognostic biomarkers in Polycystic Ovary Syndrome. Clin Chim Acta 576:120425. https:\/\/doi.org\/10.1016\/j.cca.2025.120425","journal-title":"Clin Chim Acta"},{"key":"12967_CR70","doi-asserted-by":"publisher","unstructured":"Yu Y, Tan P, Zhuang Z et al (2021) DIA proteomics analysis through serum profiles reveals the significant proteins as candidate biomarkers in women with PCOS. BMC Med Genomics 141 14:125-. https:\/\/doi.org\/10.1186\/s12920-021-00962-7","DOI":"10.1186\/s12920-021-00962-7"},{"key":"12967_CR71","doi-asserted-by":"publisher","unstructured":"Christ JP, Cedars MI (2023) Current Guidelines for Diagnosing PCOS. Diagnostics 13. https:\/\/doi.org\/10.3390\/diagnostics13061113","DOI":"10.3390\/diagnostics13061113"},{"key":"12967_CR72","doi-asserted-by":"publisher","first-page":"16512","DOI":"10.1038\/s41598-025-99622-4","volume":"151 15","author":"S Lin","year":"2025","unstructured":"Lin S, Deng Y, Huang J et al (2025) Efficacy and safety of GLP-1 receptor agonists on weight management and metabolic parameters in PCOS women: a meta-analysis of randomized controlled trials. Sci Rep 2025 151 15:16512\u2013. https:\/\/doi.org\/10.1038\/s41598-025-99622-4","journal-title":"Sci Rep 2025"},{"key":"12967_CR73","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1093\/ejendo\/lvag033","volume":"194","author":"M Forslund","year":"2026","unstructured":"Forslund M, W\u00e4ndell P, Forsberg L et al (2026) GLP-1 receptor agonist treatment in women with polycystic ovary syndrome\u2014a systematic review and meta-analysis. Eur J Endocrinol 194:S25\u2013S39. https:\/\/doi.org\/10.1093\/ejendo\/lvag033","journal-title":"Eur J Endocrinol"},{"key":"12967_CR74","doi-asserted-by":"publisher","unstructured":"Sridharan K, Sivaramakrishnan G (2025) Expanding therapeutic horizons: glucagon-like peptide-1 receptor agonists and sodium glucose transporter-2 inhibitors in poly cystic ovarian syndrome: a comprehensive review including systematic review and network meta-analysis of randomized clinical tri\u2026 Diabetol Metab Syndr 171 17:168-. https:\/\/doi.org\/10.1186\/s13098-025-01730-8","DOI":"10.1186\/s13098-025-01730-8"},{"key":"12967_CR75","doi-asserted-by":"publisher","unstructured":"Wang J, Chen R, Long H et al (2025) Artificial intelligence in polycystic ovarian syndrome management: past, present, and future. La Radiol medica 1309 130:1409\u20131441. https:\/\/doi.org\/10.1007\/s11547-025-02032-9","DOI":"10.1007\/s11547-025-02032-9"},{"key":"12967_CR76","doi-asserted-by":"publisher","first-page":"1627670","DOI":"10.3389\/frph.2025.1627670","volume":"7","author":"S Vasudevan","year":"2025","unstructured":"Vasudevan S, Gautam R, Maan P et al (2025) A sustainable public health framework for PCOS management in low- and middle-income countries: a narrative review. Front Reprod Heal 7:1627670. https:\/\/doi.org\/10.3389\/frph.2025.1627670","journal-title":"Front Reprod Heal"},{"key":"12967_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11831-025-10358-w","volume":"2025","author":"G Govindharajan","year":"2025","unstructured":"Govindharajan G, Subramanian S, Doraipandian M, Rajendran S (2025) Innovative AI-Driven Models for Predicting Polycystic Ovarian Syndrome: An Extensive Review of Machine Learning and Deep Learning Frameworks. Arch Comput Methods Eng 2025:1\u201326. https:\/\/doi.org\/10.1007\/s11831-025-10358-w","journal-title":"Arch Comput Methods Eng"},{"issue":"141","key":"12967_CR78","doi-asserted-by":"publisher","first-page":"1425012","DOI":"10.1038\/s41598-024-75964-3","volume":"2024","author":"P Moral","year":"2024","unstructured":"Moral P, Mustafi D, Mustafi A, Sahana SK (2024) CystNet: An AI driven model for PCOS detection using multilevel thresholding of ultrasound images. Sci Rep 2024(141):1425012\u2013. https:\/\/doi.org\/10.1038\/s41598-024-75964-3","journal-title":"Sci Rep"},{"key":"12967_CR79","doi-asserted-by":"publisher","first-page":"e71118","DOI":"10.2196\/71118","volume":"27","author":"Z Arabkermani","year":"2025","unstructured":"Arabkermani Z, Barzegari S, Rouhani A et al (2025) Mobile Apps Designed for Patients With Polycystic Ovary Syndrome: Content Analysis Using the Mobile App Rating Scale. J Med Internet Res 27:e71118. https:\/\/doi.org\/10.2196\/71118","journal-title":"J Med Internet Res"},{"key":"12967_CR80","doi-asserted-by":"publisher","first-page":"102927","DOI":"10.1016\/j.eclinm.2024.102927","volume":"78","author":"HJ Teede","year":"2024","unstructured":"Teede HJ, Gibson M, Laven J et al (2024) International PCOS guideline clinical research priorities roadmap: a co-designed approach aligned with end-user priorities in a neglected women\u2019s health condition. eClinicalMedicine 78:102927. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102927","journal-title":"eClinicalMedicine"},{"key":"12967_CR81","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/aogs.14725","volume":"103","author":"M Forslund","year":"2024","unstructured":"Forslund M, Melin J, Stener-Victorin E et al (2024) International evidence-based guideline on assessment and management of PCOS\u2014A Nordic perspective. Acta Obstet Gynecol Scand 103:7\u201312. https:\/\/doi.org\/10.1111\/aogs.14725","journal-title":"Acta Obstet Gynecol Scand"},{"key":"12967_CR82","doi-asserted-by":"publisher","unstructured":"Wang CC, Wu X, Yi W, Liu X (2026) Precision Targeted Therapy for PCOS: Emerging Drugs, Translational Challenges, and Future Opportunities. Biomed 14:213. https:\/\/doi.org\/10.3390\/biomedicines14010213","DOI":"10.3390\/biomedicines14010213"},{"key":"12967_CR83","doi-asserted-by":"publisher","first-page":"8867","DOI":"10.3390\/jcm14248867","volume":"14","author":"J Parker","year":"2025","unstructured":"Parker J, Hitch V (2025) New Challenges and Perspectives in Polycystic Ovary Syndrome. J Clin Med 2025 14:8867. https:\/\/doi.org\/10.3390\/jcm14248867","journal-title":"J Clin Med 2025"},{"key":"12967_CR84","doi-asserted-by":"publisher","unstructured":"Xing L, Shi M, Wang Z et al (2025) Glycolysis in polycystic ovary syndrome: pathogenesis and treatment. J Ovarian Res 18. https:\/\/doi.org\/10.1186\/s13048-025-01908-8","DOI":"10.1186\/s13048-025-01908-8"},{"key":"12967_CR85","doi-asserted-by":"publisher","first-page":"148503","DOI":"10.1016\/j.ijbiomac.2025.148503","volume":"332","author":"J Zhou","year":"2025","unstructured":"Zhou J, Guo M, Danzeng Q et al (2025) Lactate-HIF-1a axis promotes PINK1-dependent mitophagy to protect porcine granulosa cells against hypoxic stress. Int J Biol Macromol 332:148503. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.148503","journal-title":"Int J Biol Macromol"},{"key":"12967_CR86","doi-asserted-by":"publisher","first-page":"106839","DOI":"10.1016\/j.jsbmb.2025.106839","volume":"254","author":"S Li","year":"2025","unstructured":"Li S, Wu J, Lu R et al (2025) Mogroside V restores glycolytic function via LDHA promoter demethylation independent of alternative splicing in PCOS granulosa cells. J Steroid Biochem Mol Biol 254:106839. https:\/\/doi.org\/10.1016\/j.jsbmb.2025.106839","journal-title":"J Steroid Biochem Mol Biol"},{"key":"12967_CR87","doi-asserted-by":"publisher","first-page":"135580","DOI":"10.1016\/j.ijbiomac.2024.135580","volume":"280","author":"G Wu","year":"2024","unstructured":"Wu G, Pan Y, Chen M et al (2024) Lactylation drives hCG-triggered luteinization in hypoxic granulosa cells. Int J Biol Macromol 280:135580. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.135580","journal-title":"Int J Biol Macromol"},{"key":"12967_CR88","doi-asserted-by":"publisher","first-page":"e70032","DOI":"10.1002\/prca.70032","volume":"20","author":"W Wang","year":"2026","unstructured":"Wang W, Yan T, Sun M et al (2026) Increased Serum Levels of LDHA and TPI1 in Patients With Polycystic Ovary Syndrome. Proteom \u2013 Clin Appl 20:e70032. https:\/\/doi.org\/10.1002\/prca.70032","journal-title":"Proteom \u2013 Clin Appl"},{"key":"12967_CR89","doi-asserted-by":"publisher","unstructured":"Pant P, Sircar R, Prasad R et al (2023) Protein Expression and Bioinformatics Study of Granulosa Cells of Polycystic Ovary Syndrome Expressed Under the Influence of DHEA. Clin Med Insights Endocrinol Diabetes 16. https:\/\/doi.org\/10.1177\/11795514231206732","DOI":"10.1177\/11795514231206732"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12967-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12967-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12967-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:03:57Z","timestamp":1792796637000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12967-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12967"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12967-5","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]},"assertion":[{"value":"5 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1788"}}